Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Genome mining and AntiSMASH analysis of an Endophytic Talaromyces sp. reveal biosynthetic pathway gene clusters for novel bioactive compounds

Priyanka N. Shenoy, Sneha Bhaskar, M. Manu, M. P. Likitha, N. Geetha, Shailasree Sekhar, K Ramachandra Kini.




Abstract

Medicinal plants and their endophytes are one of the efficient producers of diverse secondary metabolites with therapeutic importance. In the present study, an endophytic fungus Talaromyces spp. isolated from Syzygium samarangense was subjected to whole-genome sequencing and Antibiotics and Secondary Metabolite Analysis Shell (AntiSMASH) annotation to identify biosynthetic gene clusters (BGCs) of secondary metabolites and their biosynthetic pathways. The Funannotate results revealed that the Talaromyces isolate has a total of 30.5Mb genome consisting of 372 contigs, 372 scaffolds and 47.64% GC content. In addition, 114 tRNA, 12722 functional mRNA, 12721 CDS transcripts, and 12721 protein-coding sequences were predicted and annotated using various BLAST databases. AntiSMASH revealed the presence of 76 BGCs, including 28 T1 Polyketide synthase (T1 PKS), 10 Nonribosomal peptide synthetases (NRPSs), 9 terpene, 1 Indole, 12 NRPs like, 4 T1 PKS and NRPs like, 2 T1 PKS Indole, 1 NRPs like terpene, 3 NRPs T1 PKS, 1 Indole NRPs, 2 betalactone, 1 phosphonate, 1 fungal-RiPP T1 PKS and 1 Other type. The analysis also predicted the occurrence of enzymes involved in the biosynthesis of some of the important secondary metabolites such as Pyranonigrin, Squalestatin -S, Azanigerone -A, Asperterpenoid -A, Napthopyrone, Clavaric acid, and Fusarin.

Key words: Endophytic fungi, Secondary Metabolites, AntiSMASH, Talaromyces, Biosynthetic gene clusters, Whole genome Sequence






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.